首页> 外国专利> Intrauterine use 18 - methyl - 14B, 16B - methylene - 19 nor espirox 20 - - 4 - - 3 - onas, intrauterine Systems containing 18 Methyl 14B, 16B - methylene - 19 nor espirox 20 - - 4 - - 3 - ona, as well as its use in contraception and Gynecologic Therapy

Intrauterine use 18 - methyl - 14B, 16B - methylene - 19 nor espirox 20 - - 4 - - 3 - onas, intrauterine Systems containing 18 Methyl 14B, 16B - methylene - 19 nor espirox 20 - - 4 - - 3 - ona, as well as its use in contraception and Gynecologic Therapy

机译:宫腔内使用18-甲基-14B,16B-亚甲基-19或espirox 20-4--3-onas,宫内系统含18甲基​​14B,16B-亚甲基-19或espirox 20--4-3-ona,如及其在避孕和妇科治疗中的应用

摘要

Claim 1: application of intrauterine 18 - methyl - 15B, 16B - methylene - 19 nor espirox 20 - - 4 - - 3 - onas of the General formula (1) where ru2076 and ru2077 is a hydrogen Atom or a Methyl Group - together.Claim 5: intrauterine system according to claim 3, wherein the system releases a daily dose of 200 mg 1 - 18 - methyl - 14B, 16B - methylene - 19 nor espirox 20 - - 4 - - 3 - ona.
机译:1。通式(1)的子宫内18-甲基-15B,16B-亚甲基-19或esspirox 20-4-4-3的应用,其中r u2076和r u2077是氢原子或甲基群组5:根据权利要求3所述的子宫内系统,其中所述系统释放200mg的每日剂量1-18-甲基-14B,16B-亚甲基-19或依斯匹索20 -4-4-3 -ona。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号